Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
domenica, novembre 22
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Ocugen Inc
OCGN
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$0.7679
0.0351
4.79%
In chiusura: Nov 20, 4:00 PM EST
$0.7746
0.0067
0.87%
Post-mercato: Nov 20, 7:54 PM EST
Get Report
Panoramica
Notizie
Grafici
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Rapporto azionario
Ocugen Financials
Ocugen (OCGN) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
UPDATE: Ocugen Q3 Adj. EPS $(0.06), Inline, Sales $1.951M Beat $1.098M Estimate
Ocugen (NASDAQ:OCGN) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 14.29 percent increase over losses of $(0.07) per share from the same period last year. The
Benzinga Newsdesk
PRO
Ocugen Signs Exclusive OCU400 MENA License With Roots Pharmaceutical; Eligible For Up To $4M Upfront & Milestones, Up To $255M Sales Milestones, 22% Royalty
Benzinga Newsdesk
PRO
Ocugen Receives Provisional Approval & Priority Designation For OCU400 In The Bahamas
Benzinga Newsdesk
PRO
Ocugen Sees OCU400 Phase 3 Topline Data In Q1 2027
Benzinga Newsdesk
PRO
Ocugen Q3 Cash, Equivalents & Short-Term Investments $84.6M; Sees Runway Into 2028
Benzinga Newsdesk
PRO
Ocugen Q3 EPS $(0.01) Beats $(0.06) Estimate, Sales $1.951M Beat $1.098M Estimate
Ocugen (NASDAQ:OCGN) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.06) by 83.33 percent. This is a 85.71 percent increase over losses of $(0.07) per share from the same
Benzinga Newsdesk